Skip to main content
. 2015 Oct 16;21(3):10.18553/jmcp.2015.21.3.220. doi: 10.18553/jmcp.2015.21.3.220

TABLE 1.

Antidiabetic Therapies

Antidiabetic Therapy Drug Name
Insulin Insulin aspart, insulin aspart protamine and aspart (human), insulin detemir, insulin glargine, insulin glulisine, insulin isophane, insulin isophane and regular (human), insulin isophane (human), insulin isophane (pork), insulin lispro (human), insulin lispro protamine and lispro (human), insulin regular (human) buffered, insulin regular
Noninsulin medications
Sulfonylureas Chlorpropamide, glipizide, glimepiride, glyburide
Meglitinides Repaglinide, nateglinide
Biguanides Metformin
DPP-4 inhibitors Sitagliptin, saxagliptin
Thiazolidinediones Rosiglitazone, pioglitazone
Alpha-glucosidase inhibitors Acarbose, miglitol
GLP-1 receptor agonists Exenatide, liraglutide
Amylin analogues Pramlintide
Combination drug products Metaglip (glipizide/metformin); Glucovance (glyburide/metformin); Avandamet (rosiglitazone/metformin); Actoplus Met (pioglitazone/metformin); Avandaryl (rosiglitazone/glimepiride); Duetact (pioglitazone/glimepiride); Janumet (sitagliptin/metformin)

DDP-4 = dipeptidyl peptidase-4; GLP-1 = glucagon-like peptide-1.